account_balance
Investment manager · 13F filer · SEC CIK 78003
Pfizer Inc
Reported value$164Mas of Sep 30, 2026
Positions17 1 new, 1 sold out
Top 10 weight95.1%ALLO alone is 22%
FiledNov 1243 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
ALLOAllogene Therapeutics Inc
22.1%
ARVNArvinas Inc
16.0%
CELCCelcuity Inc
14.3%
AGMBAgomab Therapeutics NV
13.8%Added +2768%
PYXSPyxis Oncology Inc
12.2%
WVEWave Life Sciences Inc
4.3%
BHVNBiohaven Ltd
4.0%
CRBUCaribou Biosciences Inc
3.5%
ORICOric Pharmaceuticals Inc
3.0%
CRDF1.8%SPRO1.8%ZNTL1.6%ALLOAllogene Therapeutics Inc
22.1%
ARVNArvinas Inc
16.0%
CELCCelcuity Inc
14.3%
AGMBAgomab Therapeutics NV
13.8%Added +2768%
PYXSPyxis Oncology Inc
12.2%
WVE4.3%BHVN4.0%CRBU3.5%ORICCRDFSPROBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
ALLO Allogene Therapeutics Inc 22.1% HeldARVN Arvinas Inc 16.0% HeldCELC Celcuity Inc 14.3% HeldAGMB Agomab Therapeutics NV 13.8% Added +2768%PYXS Pyxis Oncology Inc 12.2% HeldWVE Wave Life Sciences Inc 4.3% HeldBHVN Biohaven Ltd 4.0% HeldCRBU Caribou Biosciences Inc 3.5% HeldORIC Oric Pharmaceuticals Inc 3.0% HeldCRDF Cardiff Oncology Inc 1.8% HeldSPRO Spero Therapeutics Inc 1.8% HeldZNTL Zentalis Pharmaceuticals Inc 1.6% Held
What changed